Quick Takeaways
- Frank Karbe has 4 issuer positions tracked on this page.
- Estimated disclosed ownership value: $6,044,872.
- Recent insider filing activity is available below.
- Info
- Insider Ownership
Insider Trading & Ownership of Frank Karbe
- Location
- Brisbane, CA
- Summary
- The estimated net worth of Frank Karbe is at least $6,044,872 dollars as of 07 Jan 2026. Frank Karbe is the Principal Fin'l & Accounting of Myovant Sciences Ltd. and owns shares of Myovant Sciences Ltd. stock worth about $5.73M. Frank Karbe is the Director of Phathom Pharmaceuticals, Inc. and owns shares of Phathom Pharmaceuticals, Inc. (PHAT) stock worth about $223.4K. Frank Karbe is the Chief Executive Officer, Director of Better Therapeutics, Inc. and owns shares of Better Therapeutics, Inc. stock worth about $89.5K.
- Signature
- /s/ Shane Ward, Attorney-in-Fact
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow Frank Karbe and return when a new Insider Trading filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean.
What Changed
- Largest disclosed position: Myovant Sciences Ltd. ($5,731,992).
- Past-year value change for that position: .
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Source Evidence
Filed on Form 4
See Original Filing
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
Ownership of Frank Karbe
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| MYOV | Myovant Sciences Ltd. | Principal Fin'l & Accounting | $5,731,992 | 07 Jul 2021 | ||
| PHAT | Phathom Pharmaceuticals, Inc. | Director | $223,425 | 03 Jun 2025 | ||
| BTTX | Better Therapeutics, Inc. | Chief Executive Officer, Director | $89,455 | 18 Dec 2023 | ||
| CDTX | Cidara Therapeutics, Inc. | Chief Financial Officer | $0 | 07 Jan 2026 |
Insider Transactions Reported by Frank Karbe:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.